Retail News

Panel Opposes OTC Approval for Mevacor

Reuters 01/14/2005

Concerns about whether the drug could be used safely without a doctor’s guidance has led an advisory panel to argue against regulators approving the cholesterol drug, Mevacor, for sale over-the-counter.

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!